Skovsgaardshannon8084

We examined the effects of a dihydropyridine calcium channel blocker nilvadipine with anti-inflammatory properties on cognition and cerebrospinal fluid (CSF) biomarkers by baseline Alzheimer's disease (AD) severity. Exploratory analyses were performed on the dataset (n = 497) of a phase III randomized placebo-controlled trial to examine the response to nilvadipine in AD subjects stratified by baseline AD severity into very mild (MMSE ≥ 25), mild (MMSE 20-24) and moderate AD (MMSE less then 20). The outcome measures included total and subscale scores of the Alzheimer's Disease Assessment Scale Cognitive 12 (ADAS-Cog 12), the Clinical Dementia Rating Scale sum of boxes (CDR-sb) and the AD composite score (ADCOMS). Cerebrospinal fluid biomarkers Aβ38, Aβ40, Aβ42, neurofilament light chain (NFL), neurogranin, YKL-40, total tau and P181 tau (ptau) were measured in a subset of samples (n = 55). Regression analyses were adjusted for confounders to specifically examine the influence of nilvadipine and baseline AD s/ct2/show/NCT02017340 EUDRACT Reference Number 2012-002764-27 Registered 04 February 2013, https//www.clinicaltrialsregister.eu/ctr-search/search?query=2012-002764-27. Copyright © 2020 Abdullah, Crawford, Tsolaki, Börjesson-Hanson, Olde Rikkert, Pasquier, Wallin, Kennelly, Ait-Ghezala, Paris, Hendrix, Blennow, Lawlor and Mullan.Multiple sclerosis (MS) is a chronic, immune-mediated, inflammatory, and degenerative disease of the central nervous system (CNS) that affects both white and gray matter. Various mechanisms throughout its course, mainly regarding gray matter lesions and brain atrophy, result in cognitive network dysfunction and can cause clinically significant cognitive impairment in roughly half the persons living with MS. Altered cognition is responsible for many negative aspects of patients' lives, independently of physical disability, such as higher unemployment and divorce rates, reduced social activities, and an overall decrease in quality of life. Despite its devastating impact it is not included in clinical ratings and decision making in the way it should be. It is interesting that only half the persons with MS exhibit cognitive dysfunction, as this implies that the other half remain cognitively intact. It appears that a dynamic balance between brain destruction and brain reorganization is taking place. This balance arehabilitation and neuromodulation for cognition in MS as well as factors that influence them and prevent them from being widely applied in clinical settings. Copyright © 2020 Nasios, Bakirtzis and Messinis.Genetic generalized epilepsies (GGE), previously called idiopathic generalized epilepsies, constitute about 20% of all epilepsies, and include childhood absence epilepsy, juvenile absence epilepsy, juvenile myoclonic epilepsy, and epilepsy with generalized tonic-clonic seizures alone (CAE, JAE, JME, and GGE-GTCS, respectively). GGE are characterized by high heritability, likely underlain by polygenetic mechanisms, which may relate to atypical neurodevelopmental trajectories. Age of onset ranges from pre-school years, for CAE, to early adulthood for GGE-GTCS. Traditionally, GGE have been considered benign, a belief contrary to evidence from neuropsychology studies conducted over the last two decades. In JME, deficits in executive and social functioning are common findings and relate to impaired frontal lobe function. Studies using neuropsychological measures and cognitive imaging paradigms provide evidence for hyperconnectivity between prefrontal and motor cortices, aberrant fronto-thalamo-cortical connectivitophenotype), independent of seizures and anti-epileptic medication. Copyright © 2020 Ratcliffe, Wandschneider, Baxendale, Thompson, Koepp and Caciagli.The regenerative capability of the central nervous system is limited after traumatic spinal cord injury (SCI) due to intrinsic and extrinsic factors that inhibit spinal cord regeneration, resulting in deficient functional recovery. It has been shown that strategies, such as pre-degenerated peripheral nerve (PPN) grafts or the use of bone marrow stromal cells (BMSCs) or exogenous molecules, such as chondroitinase ABC (ChABC) promote axonal growth and remyelination, resulting in an improvement in locomotor function. These treatments have been primarily assessed in acute injury models. The aim of the present study is to evaluate the ability of several single and combined treatments in order to modify the course of chronic complete SCI in rats. A complete cord transection was performed at the T9 level. One month later, animals were divided into five groups original injury only (control group), and original injury plus spinal cord re-transection to create a gap to accommodate BMSCs, PPN, PPN + BMSCs, and PPN + BMSCs + ChABC. In comparison with control and single-treatment groups (PPN and BMSCs), combined treatment groups (PPN + BMSCs and PPN + BMSCs + ChABC) showed significative axonal regrowth, as revealed by an increase in GAP-43 and MAP-1B expression in axonal fibers, which correlated with an improvement in locomotor function. In conclusion, the combined therapies tested here improve locomotor function by enhancing axonal regeneration in rats with chronic SCI. Further studies are warranted to refine this promising line of research for clinical purposes. Copyright © 2020 Buzoianu-Anguiano, Rivera-Osorio, Orozco-Suárez, Vega-García, García-Vences, Sánchez-Torres, Jiménez-Estrada, Guizar-Sahagún, Mondragon-Caso, Fernández-Valverde, Madrazo and Grijalva.Traumatic brain injury (TBI) constitutes a global epidemic. Overall outcome is poor, with mortality ranging from 10 to 70% and significant long-term morbidity. Several experimental reports have claimed effect on traumatic edema, but all clinical trials have failed. Antisecretory factor, an endogenous protein, is commercially available as Salovum®, which is classified as a medical food by the European Union and has been proven effective in experimental trauma models. It has, however, previously not been tested in humans with severe TBI. We hereby report a case series of five adult patients with severe TBI, treated with Salovum. The objective of the intervention was to evaluate safety and, if possible, its effect on intracranial pressure and outcome. Patients received 1 g Salovum per kilo of body weight divided into six doses per 24 h. Each dose was administered through the nasogastric tube. Patients were scheduled for 5 days of treatment with Salovum. Intracranial pressure was controlled in all patients. In three of five patients, intracranial pressure could be controlled with Salovum and deep sedation (no barbiturates), except during periods of gastroparesis. Five of five patients had a favorable short-term outcome, and four of five patients had a favorable long-term outcome. No toxicity was observed. We conclude that at least three of the five treated patients experienced an effect of Salovum with signs of reduction of intracranial pressure and signs of clinical benefit. In order to validate the potential of antisecretory factor in TBI, a prospective, randomized, double-blind, placebo-controlled trial with Salovum has been initiated. Primary outcome for the trial is 30-day mortality; secondary outcomes are treatment intensity level, intracranial pressure, and number of days at the neurointensive care unit. Copyright © 2020 Cederberg, Hansson, Visse and Siesjö.The current article proposes integrating a functional behavior approach to the study of culture. After describing culture from a contextual behavioral science framework, we outline a three-step process to perform a functional behavior analysis of culture (1) identifying potential contingencies, (2) determining functional relationships, and (3) gathering supporting evidence. As an example, we present each of the three steps through a re-analysis of data related to cultural differences in social anxiety between Japanese and European Americans as well as describe a hypothetical experiment. The results demonstrate how implementing an alternative framework that focuses on the relationship between behavioral function and environmental adaptability leads to different conclusions compared to implementing frameworks that emphasize the form or degree of a behavior or belief in one group compared to another. For this particular example, in contrast to viewing social anxiety in Japanese as something stemming from innate beliefs about themselves and others (e.g., self-construal), the current study suggests that displaying social anxiety in some situations within a Japanese context is more functionally adaptive (e.g., more likely leads to desirable outcomes) than within a European American context. Copyright © 2020 Krieg.Objective To examine the effectiveness of self-weighing for weight loss in men for 6 months. Methods In the present study, 54 men, mean age of 40.1 ± 11.1 years, with overweight or obesity, were recruited and randomly assigned into two groups control group (CG), without weight self-monitoring and intervention group (IG), with weight self-monitoring. Both groups received the same nutritional and educational advice and the establishment of a weight target to reach in the weight loss program. Subjects of IG also had individualized motivating content to improve self-management for 24 weeks. Anthropometric indices were measured at baseline and weekly for 24 weeks. Results When the group assigned after randomization was introduced in the analysis, its influence was significant in weight loss (F1.52 = 19.465, ± 2 = 0.272, p less then 0.001) and in the decrease in body fat percentage (F1.52 = 8,306, ± 2 = 0.132, p less then 0.01). Conclusion Study results indicate that self-weighing can help patients to lose additional weight. Our findings have implications in the emerging area of the behavioral approach of patients undergoing weight-loss treatment, as well as clinical care processes. Clinical Trial Registration www.ClinicalTrials.gov, identifier NCT04032249. Copyright © 2020 Hernández-Reyes, Cámara-Martos, Vidal, Molina-Luque and Moreno-Rojas.The proficiency of human observers to identify body postures is examined in three experiments. We use a posture decision task in which participants are primed with either anatomically possible or impossible postures (in the latter case the upper and lower body face in opposite directions). In a long-term priming paradigm (i.e., in an initial priming block of trials and a subsequent test phase several minutes later), we manipulate the relation between priming and test postures with respect to the identity of the person in the body postures (Experiment 1), the prototypicality of the depth orientations (Experiment 2), and the variability of the priming orientations (Experiment 3). Reaction time to the test postures is the main dependent variable. In Experiment 1 it is found that priming of postures does not depend on the exact visual appearance of the actor (either same priming and test female or male figure or different figures), supporting the hypothesis that posture priming primarily is determined by the spatial relations between the body parts and much less by characteristics of the person involved. Long-term priming in our paradigm apparently is based on the reactivation of high-level posture representations that make abstraction of the identity of the human figure. In Experiment 2 we observe that privileged or prototypical orientations (e.g., 3/4 views) do not affect long-term priming of body postures. In Experiment 3, we find that increasing or decreasing the variability between the priming and test figures influences reaction time performance. Collectively, these results provide a better understanding of the flexibility (e.g., invariant to identity) and limits (e.g., depending on depth orientation) of the processes supporting human posture recognition. Copyright © 2020 Verfaillie and Daems.